Effect of<i>l</i>-Deprenyl and Gliclazide on Oxidant Stress/Antioxidant Status and DNA Damage in a Diabeticrat Model

Abstract

The combined treatment of deprenyl and gliclazide may contribute to the control of the physiopathological mechanisms underlying both the process of aging and type 2 diabetes by reducing oxidant stress and DNA damage, improving antioxidant status, and increasing survival, and may have implications for further clinical studies.